Declaration of Istanbul

Last updated

The Declaration of Istanbul was created at the Istanbul Summit on Organ Trafficking and Transplant Tourism held from 30 April to 1 May 2008 in Istanbul, Turkey. [1] The Declaration clarifies the issues of transplant tourism, trafficking and commercialism and provides ethical guidelines for practice in organ donation and transplantation. Since the creation of the declaration, over 100 countries have endorsed the principles. Some nations have subsequently strengthened their laws against commercial organ trade, including China, Israel, the Philippines, and Pakistan. [2]

Contents

History

As a consequence of the widespread shortage of organs and the increasing ease of Internet communication, organ trafficking and transplant tourism have become global problems accounting for an estimated 10% of organ transplants that are performed annually around the world. [3] Organ trafficking, transplant tourism and transplant commercialism threaten to undermine the nobility and legacy of transplantation worldwide because of the reality associated with these practices – the vulnerable in resource poor countries (such as the illiterate and impoverished, undocumented immigrants, prisoners, and political or economic refugees) are exploited for their organs as a major source of organs for the rich patient-tourists who are prepared to travel and can afford to purchase organs.

The Istanbul Summit

These unethical practices were the subject of a Summit convened in Istanbul from 30 April to 1 May 2008 by The Transplantation Society (TTS) [4] and the International Society of Nephrology (ISN). [5] The result of these deliberations was the Istanbul Declaration on Organ Trafficking and Transplant Tourism . The development of the Istanbul Summit and Declaration was derived from a direction by the World Health Assembly in 2004 as it adopted resolution WHA57.18 urging member states ‘to take measures to protect the poorest and vulnerable groups from transplant tourism and the sale of tissues and organs, including attention to the wider problem of international trafficking in human tissues and organs’. [6]

Content of the Declaration of Istanbul

The Declaration emphasizes that organ trafficking and transplant tourism should be prohibited because they violate the principles of equity, justice and respect for human dignity. The Declaration asserts that because transplant commercialism targets impoverished and otherwise vulnerable donors, it leads inexorably to inequity and injustice and should also be prohibited.

Although the World Health Assembly 2004 resolution was unambiguous in its objection to trafficking and transplant tourism, a comprehensive description of these unethical practices was still needed. Organ trafficking, transplant tourism and transplant commercialism are now defined by the Declaration, and it provides principles of practice based on those definitions. The Istanbul Declaration distinguishes transplant tourism from travel for transplantation. Travel for transplantation is the movement of organs, donors, recipients or transplant professionals across jurisdictional borders for transplantation purposes. Travel for transplantation becomes transplant tourism if (1) it involves organ trafficking and/or transplant commercialism or; (2) if the resources (organs, professionals and transplant centers) devoted to providing transplants to patients from outside a country undermine the country’s ability to provide transplant services for its own population.

Not all recipients’ travel to a foreign country to undergo transplantation is unethical. Travel for transplantation may be ethical if the following conditions are fulfilled:

For live donor transplantation:

(1) if the recipient has a dual citizenship and wishes to undergo transplantation from a live donor that is a family member in a country of citizenship that is not their residence;

(2) if the donor and recipient are genetically related and wish to undergo transplantation in a country not of their residence.

For deceased donor transplantation:

(1) if official regulated bilateral or multilateral organ sharing programs exist between or among jurisdictions that are based on reciprocated organ-sharing programs among the jurisdictions.

See also

Related Research Articles

Nephrology

Nephrology is a specialty of adult internal medicine and pediatric medicine that concerns with study of the kidneys, specifically normal kidney function and kidney disease, the preservation of kidney health, and the treatment of kidney disease, from diet and medication to renal replacement therapy. The word “renal” is an adjective meaning “relating to the kidneys”, and its roots are French or late Latin. Whereas according to some opinions, "renal" and "nephro" should be replaced with "kidney" in scientific writings such as "kidney medicine" or "kidney replacement therapay", other experts have advocated preserving the use of renal and nephro as appropriate including in "nephrology" and "renal replacement therapy", respectively.

Organ donation Use of donated organs for transplantation or research

Organ donation is the process when a person allows an organ of their own to be removed and transplanted to another person, legally, either by consent while the donor is alive or dead with the assent of the next of kin.

Organ transplantation Medical procedure in which an organ is removed from one body and placed in the body of a recipient

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

Immunosuppression

Immunosuppression is a reduction of the activation or efficacy of the immune system. Some portions of the immune system itself have immunosuppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions.

Transplant rejection Rejection of transplanted tissue by the recipients immune system

Transplant rejection occurs when transplanted tissue is rejected by the recipient's immune system, which destroys the transplanted tissue. Transplant rejection can be lessened by determining the molecular similitude between donor and recipient and by use of immunosuppressant drugs after transplant.

Kidney transplantation Medical procedure

Kidney transplant or renal transplant is the organ transplant of a kidney into a patient with end-stage kidney disease (ESRD). Kidney transplant is typically classified as deceased-donor or living-donor transplantation depending on the source of the donor organ. Living-donor kidney transplants are further characterized as genetically related (living-related) or non-related (living-unrelated) transplants, depending on whether a biological relationship exists between the donor and recipient.

Organ transplantation in China

Organ transplantation in China has taken place since the 1960s, and is one of the largest organ transplant programmes in the world, peaking at over 13,000 liver and kidney transplants a year in 2004. Involuntary organ harvesting is illegal under Chinese law; though, under a 1984 regulation, it became legal to remove organs from executed criminals with the prior consent of the criminal or permission of relatives. Growing concerns about possible ethical abuses arising from coerced consent and corruption led medical groups and human rights organizations, by the 1990s, to condemn the practice. These concerns resurfaced in 2001, when a Chinese asylum-seeking doctor testified that he had taken part in organ extraction operations.

Tissue typing is a procedure in which the tissues of a prospective donor and recipient are tested for compatibility prior to transplantation. Mismatched donor and recipient tissues can lead to rejection of the tissues. There are multiple methods of tissue typing.

Organ procurement is a surgical procedure that removes organs or tissues for reuse, typically for organ transplantation.

Organ trade is the trading of human organs, tissues, or other body products, usually for transplantation. According to the World Health Organization (WHO), organ trade is a commercial transplantation where there is a profit, or transplantations that occurs outside of national medical systems. There is a global need or demand for healthy body parts for transplantation, which exceeds the numbers available.

Mehmet Haberal

Mehmet Haberal, is the founder of Başkent University in Ankara, Turkey, best known for becoming the first transplant surgeon in Turkey after leading the team that performed Turkey's first living-related kidney transplant in 1975, after he returned from surgical training under the mentorship of American surgeon Thomas Starzl, with whom he also performed some of the longest surviving early liver transplantations.

Organ transplantation in Israel has historically been low compared to other Western countries due to a common belief that organ donation is prohibited under Jewish law. This changed with the passage of new organ donation laws in 2008. If two patients have the same medical need, priority will now go to the patient who has signed an organ donor card, or whose family members have donated an organ. This policy was nicknamed don't give, don't get. The law also defines "brain death" as an indication of death for all legal purposes, including organ donation. Additionally the law provides financial reimbursement to living donors for medical expenses due to donation and lost time at work. Organ trafficking is explicitly banned. Health insurance plans can no longer reimburse patients who go abroad to receive transplants.

Mahamane Kalil Maiga is a Malian scientist and politician. He served as Minister of Defense and Armed Forces of Mali from 2002 to 2004, under the administration of President Amadou Toumani Touré.

Francis L. Delmonico

Francis L. Delmonico, MD, FACS is a surgeon, clinical professor and health expert in the field of transplantation. He serves on numerous committees and is affiliated with various leading organizations and institutions. He is the Chief Medical Officer of the New England Organ Bank (NEOB) and Professor of Surgery, Part-Time at Harvard Medical School in Boston, Massachusetts where he is Emeritus Director of Renal Transplantation. He served as President of The Transplantation Society (TTS) from 2012-2014, an international non-profit organization based in Montreal, Canada that works with international transplantation physicians and researchers. He also served as the President of the United Network of Organ Sharing (UNOS) in 2005 which overseas the practice of organ donation and transplantation in the United States. He was appointed and still serves as an advisor to the World Health Organization in matters of organ donation and transplantation. He was appointed by Pope Francis to the Pontifical Academy of Science in 2016. In 2020, he became the recipient of the Medawar Prize of The Transplantation Society.

In bioethics, ethics of organ transplantation refers to the ethical concerns on organ transplantation procedures. Both the source and method of obtaining the organ to transplant are major ethical issues to consider, as well as the notion of distributive justice.

Organ harvesting from Falun Gong practitioners in China Human rights controversy

Forced organ harvesting from Falun Gong practitioners and other political prisoners in China has raised increasing concern within the international community. According to a report by former lawmaker David Kilgour, human rights lawyer David Matas and journalist Ethan Gutmann, political prisoners, mainly Falun Gong practitioners, are being executed "on demand" in order to provide organs for transplant to recipients. The organ harvesting has taken place both as a result of the Chinese Communist Party's persecution of Falun Gong and because of the financial incentives available to the institutions and individuals involved in the trade.

Organ donation is when a person gives their organs after they die to someone in need of new organs. Transplantation is the process of transplanting the organs donated into another person. This process extends the life expectancy of a person suffering from organ failure. Unfortunately the number of patients requiring organ transplants outweighs the number of donor organs available.

Elmi Muller is a South African medical specialist who specialised in General Surgery and Transplantation. She currently performs kidney as well as liver transplants in both adults and children. She is the past President of the Southern African Transplantation Society who pioneered an organ transplant programme at Groote Schuur Hospital in Cape Town for HIV positive patients using HIV positive donors. She also serves on the Executive committee of The Transplantation Society of which she currently is the vice-president. Elmi is the Chair/Head of the Division of General Surgery at Groote Schuur Hospital, University of Cape Town.

Human organ trafficking in Egypt, mainly practiced in Cairo and the Sinai Peninsula, include organ harvesting with induced consent, coercion, and outright theft. Egypt has become the largest hub of organ transplant in North Africa as one of the few countries that prohibited organ donation from deceased donors until 2010, with over 500 kidney transplant operations a year and the majority of these organs come from living donors. Organ sources in the trafficking process mainly come from vulnerable populations including domestic rural migrants, undocumented asylum seekers and informal labor. The emergence of cultural and religious increase in organ trade and transplant tourism contribute to the rocketing demand for organ trafficking market in Egypt. Human organ trafficking poses both physical and mental health consequences for victims. Although Egypt has been gradually updating legal frameworks to combat organ trafficking, the regulation has failed in reality protecting survivors and governing transplant professionals.

Organ futures is the short term used in academic proposals for futures contracts on organs from human cadavers. They are not legal anywhere at this time.

References

  1. ↑ Participants in the International Summit on Transplant Tourism and Organ Trafficking convened by The Transplantation Society and International Society of Nephrology in Istanbul, Turkey, 30 April to 2 May 2008. "The Declaration of Istanbul on Organ Trafficking and Transplant Tourism." Kidney International 74, no. 7 (2008): 854-59.
  2. ↑ Ambagtsheer, F., and W. Weimar. 2011. "A Criminological Perspective: Why Prohibition of Organ Trade Is Not Effective and How the Declaration of Istanbul Can Move Forward." American Journal of Transplantation 12, no. 3: 571-575.
  3. ↑ Shimazono, Y. "The State of the International Organ Trade: A Provisional Picture Based on Integration of Available Information." Bulletin of the World Health Organization 85 (2007): 955-62.
  4. ↑ The Transplantation Society
  5. ↑ International Society of Nephrology
  6. ↑ World Health Organization. "Human Organ and Tissue Transplantation. (WHA 57.18)" (2004).
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.